Supplementary Figure S2 from Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer
Year: 2026
Type: supplementary-materials
Abstract: In vivo immunophenotypic analysis and therapeutic efficacy of meso-CAR-T cell monotherapy or in combination with ibrutinib against pancreatic tumors.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7127656830